Evidence map›Paper›PMID 35550620›Full record

ArticlePLoS medicine2022

Incidence of chikungunya virus infections among Kenyan children with neurological disease, 2014-2018: A cohort study.

Doris K Nyamwaya, Mark Otiende, Lilian Mwango, Symon M Kariuki, Berrick Otieno, Donwilliams O Omuoyo, George Githinji, Barnes S Kitsao, Henry K Karanja, John N Gitonga and 9 more

Open access · goldAbstract read
In one paragraph

Article in PLoS medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 3 countries.

Doris K NyamwayaKEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.ORCID 0000-0003-1834-3880
Mark OtiendeKEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.ORCID 0000-0002-1389-1813
Lilian MwangoKEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
Symon M KariukiKEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.ORCID 0000-0002-3934-5132
Berrick OtienoKEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.ORCID 0000-0002-5017-1671
Donwilliams O OmuoyoKEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.ORCID 0000-0003-3900-5354
George GithinjiKEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.ORCID 0000-0001-9640-7371
Barnes S KitsaoKEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
Henry K KaranjaKEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
John N GitongaKEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
Zaydah R de LaurentKEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.ORCID 0000-0002-2619-0856
Alun DaviesKEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.ORCID 0000-0001-7784-9000
Salim MwarumbaKEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.ORCID 0000-0002-8172-3715
Charles N AgotiKEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
Samuel M ThumbiPaul G Allen School for Global Animal Health, Washington State University, Washington, United States of America.ORCID 0000-0002-5754-0556
Mainga M HamalubaKEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.ORCID 0000-0002-0266-1414
Charles R NewtonKEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
Philip BejonKEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.ORCID 0000-0002-2135-7549
George M WarimweKEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.ORCID 0000-0002-4911-6333
Kenya Medical Research Institute · KEUniversity of Nairobi · KE

Funding

Department of HealthWellcome TrustWellcome Trust 203077_Z_16_Z
6 · The paper itself

Abstract

backgroundNeurological complications due to chikungunya virus (CHIKV) infection have been described in different parts of the world, with children being disproportionately affected. However, the burden of CHIKV-associated neurological disease in Africa is currently unknown and given the lack of diagnostic facilities in routine care it is possible that CHIKV is an unrecognized etiology among children with encephalitis or other neurological illness. METHODS AND

findingsWe estimated the incidence of CHIKV infection among children hospitalized with neurological disease in Kilifi County, coastal Kenya. We used reverse transcriptase polymerase chain reaction (RT-PCR) to systematically test for CHIKV in cerebrospinal fluid (CSF) samples from children aged <16 years hospitalized with symptoms of neurological disease at Kilifi County Hospital between January 2014 and December 2018. Clinical records were linked to the Kilifi Health and Demographic Surveillance System and population incidence rates of CHIKV infection estimated. There were 18,341 pediatric admissions for any reason during the 5-year study period, of which 4,332 (24%) had CSF collected. The most common clinical reasons for CSF collection were impaired consciousness, seizures, and coma (47%, 22%, and 21% of all collections, respectively). After acute investigations done for immediate clinical care, CSF samples were available for 3,980 admissions, of which 367 (9.2%) were CHIKV RT-PCR positive. Case fatality among CHIKV-positive children was 1.4% (95% CI 0.4, 3.2). The annual incidence of CHIKV-associated neurological disease varied between 13 to 58 episodes per 100,000 person-years among all children <16 years old. Among children aged <5 years, the incidence of CHIKV-associated neurological disease was 77 per 100,000 person-years, compared with 20 per 100,000 for cerebral malaria and 7 per 100,000 for bacterial meningitis during the study period. Because of incomplete case ascertainment due to children not presenting to hospital, or not having CSF collected, these are likely minimum estimates. Study limitations include reliance on hospital-based surveillance and limited CSF sampling in children in coma or other contraindications to lumbar puncture, both of which lead to under-ascertainment of incidence and of case fatality.

conclusionsIn this study, we observed that CHIKV infections are relatively more common than cerebral malaria and bacterial meningitis among children hospitalized with neurological disease in coastal Kenya. Given the wide distribution of CHIKV mosquito vectors, studies to determine the geographic extent of CHIKV-associated neurological disease in Africa are essential.

Indexed as

Chikungunya FeverChikungunya virusMalaria, CerebralMeningitis, BacterialNervous System DiseasesAdolescentAnimalsChildCohort StudiesComaHumansIncidenceKenya

Identifiers

PMID35550620
PMCPMC9135332
OpenAlexW4280560584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.